Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells

Precise rare-cell technologies require the blood to be processed immediately or be stabilized with fixatives. Such restrictions limit the translation of circulating tumor cell (CTC)-based liquid biopsy assays that provide accurate molecular data in guiding clinical decisions. Here we describe a meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Keith H. K., Tessier, Shannon N., Miyamoto, David T., Miller, Kathleen L., Bookstaver, Lauren D., Carey, Thomas R., Stannard, Cleo J., Thapar, Vishal, Tai, Eric C., Vo, Kevin D., Emmons, Erin S., Pleskow, Haley M., Sandlin, Rebecca D., Sequist, Lecia V., Ting, David T., Haber, Daniel A., Maheswaran, Shyamala, Stott, Shannon L., Toner, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700979/
https://www.ncbi.nlm.nih.gov/pubmed/29170510
http://dx.doi.org/10.1038/s41467-017-01705-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700979/
https://www.ncbi.nlm.nih.gov/pubmed/29170510
http://dx.doi.org/10.1038/s41467-017-01705-y

Ejemplares similares